Tempest closes acquisition of dual-targeting CAR-T assets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. CRWV
3. JBHT
4. GPRK
5. SCHW
6. TSLA
7. TRV
8. TFC
9. TECHM:IN
10. NVDA

Go back to Tempest closes acquisition of dual-targeting CAR-T assets

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

February 4, 2026 4:47 PM EST

All-stock transaction brings Tempest a portfolio of next-generation CAR-T assets, including TPST-2003, a clinical-stage dual-targeting CD-19/BCMA CAR-T with strategic partner-funded BLA filing in China planned for 2027Operational runway extended to mid-2027, supporting multiple potential value-generating milestonesMatt Angel, Ph.D., joins Tempest as President and CEOPreviously announced transaction closed following stockholder approval of share issuance at the 2025 Annual Meeting on January 27, 2026

BRISBANE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq:... More